Champions Oncology CSBR
NASDAQ CSBR
$4.81 -0.09 (-1.84%)
As of: Oct 14, 2026 · 3:50 PM EDT

Champions Oncology (CSBR) Non Operating Investment Income (2025 - 2026)

Updated

Champions Oncology (CSBR) reported Non Operating Investment Income of -$1,000 for fiscal Q4 2026 (quarter ended Apr 30, 2026), compared with -$293,000 a year earlier.

Analysis

Champions Oncology (CSBR) Non Operating Investment Income (2025 - 2026) Analysis & Trends

For FY2026 (ended Apr 30, 2026), Champions Oncology posted Non Operating Investment Income of -$111,000.

  • By fiscal year, Non Operating Investment Income came in at -$293,000 in FY2025 and -$435,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Iqvia Holdings 43.58 Bn 35.28 Bn 1.44 Bn -
2 Medpace Holdings 17.39 Bn 15.45 Bn 201.64 Mn -
3 Charles River Laboratories International 14.59 Bn 13.78 Bn 363.37 Mn -
4 Icon 13.27 Bn 10.38 Bn 479.29 Mn -32.95 Mn
5 Fortrea Holdings 2.03 Bn 1.41 Bn 139.20 Mn -
6 Ginkgo Bioworks Holdings 716.57 Mn -45.52 Mn 18.44 Mn 1.99 Mn
7 Evotec SE 506.10 Mn -1.10 Bn - -
8 Champions Oncology 66.85 Mn 41.93 Mn 7.70 Mn -
9 MindWalk Holdings 63.92 Mn 27.58 Mn 1.61 Mn -
10 Natural Alternatives International 6.75 Mn -21.33 Mn 1.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 -1,000.00
Jan 31, 2026 -89,000.00
Jul 31, 2025 -20,000.00
Apr 30, 2025 -293,000.00
API Access

Champions Oncology Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=CSBR&period=max&api_key=YOUR_API_KEY